Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Gut|November 20, 2014
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteriaYu-Jen Fang, Jyh-Ming Liou, Chieh-Chang Chen, et al.
Gastroenterology|July 3, 2018
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori InfectionJyh-Ming Liou, Po-Yueh Chen, Jiing-Chyuan Luo, et al.
Journal of Gastroenterology and Hepatology|November 14, 2025
Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver DiseaseYun-Chu Chen, Yu-Ping Chang, Ji-Yuh Lee, et al.
Journal of Medical Virology|January 15, 2026
Effect of Glycated Hemoglobin Levels on Serum Mac-2 Binding Protein Glycosylation Isomer in the Diagnosis of Hepatitis C-Virus Related Hepatic FibrosisYu-Ping Chang, Yun-Chu Chen, Ji-Yuh Lee, et al.
Plos One|May 6, 2015
The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide StudyJyh-Ming Liou, Chi-Yang Chang, Mei-Jyh Chen, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2012
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trialJyh-Ming Liou, Chieh-Chang Chen, Chi-Yang Chang, et al.
Lancet (London, England)|November 20, 2012
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trialJyh-Ming Liou, Chieh-Chang Chen, Mei-Jyh Chen, et al.
Helicobacter|July 18, 2022
Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysisMei-Jyh Chen, Ming-Jong Bair, Po-Yueh Chen, et al.
The Lancet. Infectious Diseases|September 28, 2019
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trialJyh-Ming Liou, Chieh-Chang Chen, Chih-Min Chang, et al.
The American Journal of Gastroenterology|February 3, 2016
Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized TrialJyh-Ming Liou, Ming-Jong Bair, Chieh-Chang Chen, et al.
Pageof 3